News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News Oct 18, 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News Apr 26, 2023 Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz Siegfried will create a new global R&D Center in Evionnaz, investing CHF 25 million to boost capacity, drive growth, and leading to the creation ...
Actualités Oct 26, 2022 Le fabricant chinois de vaccins CanSino Biologics s’installe à Genève pour lancer son vaccin Covid inhalé Ce premier vaccin Covid inhalé a été approuvé par les autorités chinoises il y a un mois. Cette technologie a également le potentiel de protéger ...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Actualités Sep 13, 2021 Incyte inaugure sa nouvelle usine de production à Yverdon Après avoir installé en 2020 son siège européen à Morges, le groupe biopharmaceutique américain Incyte renforce sa présence dans le canton de Vau...
News Oct 26, 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News Sep 13, 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
News Nov 04, 2021 INTEGRA Biosciences builds campus in Graubünden The laboratory equipment specialist INTEGRA Biosciences AG is expanding its headquarters in Zizers in the Greater Zurich Area. It plans to build ...
News Mar 31, 2022 Investment projects reach pre-COVID level The Greater Zurich Area attracted 125 new companies to its nine cantons in 2021. They are planning to create more than 1,800 new jobs in sectors ...
News Sep 30, 2021 Basel Area becomes the Swiss hotspot for Chinese pharma companies More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them is Hengrui...
Aktuell Nov 04, 2021 INTEGRA Biosciences baut Campus in Graubünden Die auf Laborgeräte spezialisierte INTEGRA Biosciences AG erweitert ihren Firmensitz in Zizers, in der Greater Zurich Area. Entstehen soll ein Ca...
Aktuell Mar 31, 2022 Ansiedlungen erreichen Vor-Corona-Niveau Die Greater Zurich Area hat 2021 in ihren neun Mitgliedskantonen 125 Firmen ansiedeln können. Diese wollen über 1800 Arbeitsplätze etwa in den Li...
S-GE Event Tomorrow's Health: Meet the Experts on Diagnostics and AI Jun 17, 2021 Jun 17, 2021 Switzerland
Aktuell Sep 30, 2021 Basel Area wird zum Schweizer Hotspot für chinesische Pharmafirmen Immer mehr chinesische Pharmaunternehmen wählen die Basel Area als Standort für ihre Niederlassung in der Schweiz. Unter ihnen ist Hengrui Medici...
Investir en Suisse Promotion des investissements en Suisse depuis l'étranger Les représentations de S-GE à l’étranger sont structurées en Swiss Business Hubs (SBH).